Published in Neurosci Lett on August 30, 2017
Neurotransmitter functions of mammalian tachykinins. Physiol Rev (1993) 2.59
Substance P raises neuronal membrane excitability by reducing inward rectification. Nature (1985) 1.63
Neurogenic vasodilatation and plasma leakage in the skin. Gen Pharmacol (1998) 1.54
Excitatory action of hypothalamic substance P on spinal motoneurones of newborn rats. Nature (1974) 1.45
Neural circuitry of stress-induced insomnia in rats. J Neurosci (2008) 1.32
The tachykinin NK1 receptor. Part II: Distribution and pathophysiological roles. Neuropeptides (1998) 1.32
Desensitization of the neurokinin-1 receptor (NK1-R) in neurons: effects of substance P on the distribution of NK1-R, Galphaq/11, G-protein receptor kinase-2/3, and beta-arrestin-1/2. Mol Biol Cell (1998) 1.24
Substance P opens cation channels and closes potassium channels in rat locus coeruleus neurons. Neuroscience (1992) 1.19
Neuroanatomical localisation of Substance P in the CNS and sensory neurons. Neuropeptides (2000) 1.12
Protein kinase C is involved in neurokinin receptor modulation of N- and L-type Ca2+ channels in DRG neurons of the adult rat. J Neurophysiol (2003) 1.05
Interactions of inflammatory mediators stimulating release of calcitonin gene-related peptide, substance P and prostaglandin E(2) from isolated rat skin. Neuropharmacology (2001) 0.99
Involvement of cytokines in slow wave sleep. Prog Brain Res (2011) 0.98
Multiphase CT angiography versus single-phase CT angiography: comparison of image quality and radiation dose. AJNR Am J Neuroradiol (2008) 0.95
Autoradiographic distribution of tachykinin NK2 binding sites in the rat brain: comparison with NK1 and NK3 binding sites. Neuroscience (2003) 0.91
Serotonin and substance P co-exist in dorsal raphe neurons of the human brain. Neuroreport (1999) 0.90
Cortical nNOS neurons co-express the NK1 receptor and are depolarized by Substance P in multiple mammalian species. Front Neural Circuits (2012) 0.87
Efficacy of vestipitant, a neurokinin-1 receptor antagonist, in primary insomnia. Sleep (2013) 0.85
Substance P hyperpolarizes vagal sensory neurones of the ferret. J Physiol (1996) 0.85
Sensitization of spinal cord nociceptive neurons with a conjugate of substance P and cholera toxin. BMC Neurosci (2007) 0.83
Central sensitization in the trigeminal nucleus caudalis produced by a conjugate of substance P and the A subunit of cholera toxin. J Pain (2010) 0.83
Substance P regulates Ih via a NK-1 receptor in vagal sensory neurons of the ferret. J Neurophysiol (1998) 0.83
Localization of tachykinin receptors and Fos-like immunoreactivity induced by substance P in guinea-pig brain. Clin Exp Pharmacol Physiol (2000) 0.83
Sleep disturbance induced by substance P in mice. Behav Brain Res (2005) 0.82
Interactions between excitatory amino acids and tachykinins in the rat spinal dorsal horn. Brain Res Bull (1993) 0.82
Effects of the neuropeptide substance P on sleep, mood, and neuroendocrine measures in healthy young men. Neuropsychopharmacology (2002) 0.81
Substance P promotes sleep in the ventrolateral preoptic area of rats. Brain Res (2004) 0.81
Activation of microglia by histamine and substance P. Cell Physiol Biochem (2014) 0.81
Chemosensitivity of C-cells in bullfrog dorsal root ganglia to substance P and adenosine 5'-triphosphate. Neurosci Lett (1993) 0.80
Substance P actions on sensory neurons. Ann N Y Acad Sci (1991) 0.80
Substance P and the neurokinin-1 receptor regulate electroencephalogram non-rapid eye movement sleep slow-wave activity locally. Neuroscience (2014) 0.77
Substance P and primary afferent transmission. Adv Biochem Psychopharmacol (1976) 0.77
Ketamine suppresses the substance P-induced production of IL-6 and IL-8 by human U373MG glioblastoma/astrocytoma cells. Int J Mol Med (2017) 0.76
Characteristics of dorsal root ganglia neurons sensitive to Substance P. Mol Pain (2014) 0.75
Functions and Mechanisms of Sleep. AIMS Neurosci (2016) 0.75
The NLRP3 inflammasome modulates sleep and NREM sleep delta power induced by spontaneous wakefulness, sleep deprivation and lipopolysaccharide. Brain Behav Immun (2017) 0.75
Feed-forward inhibition: a novel cellular mechanism for the analgesic effect of substance P. Mol Pain (2005) 0.75